APA (7th ed.) Citation

L, Q., J, Y., L, L., & Q, J. (2026). IL-32 as a potential biomarker and therapeutic target in cardiovascular disease. Frontiers in immunology, 17, 1755759. https://doi.org/10.3389/fimmu.2026.1755759

Chicago Style (17th ed.) Citation

L, Qiu, Ye J, Liu L, and Ji Q. "IL-32 as a Potential Biomarker and Therapeutic Target in Cardiovascular Disease." Frontiers in Immunology 17 (2026): 1755759. https://doi.org/10.3389/fimmu.2026.1755759.

MLA (9th ed.) Citation

L, Qiu, et al. "IL-32 as a Potential Biomarker and Therapeutic Target in Cardiovascular Disease." Frontiers in Immunology, vol. 17, 2026, p. 1755759, https://doi.org/10.3389/fimmu.2026.1755759.